HOME > April 10, 2020
Daily News
April 10, 2020
- Manufacturer Restresses Caution against BCG Vaccine’s Off-Label Use for COVID-19
April 10, 2020
- Sanofi Launches Kevzara Trial for Severe COVID-19 in Japan
April 10, 2020
- Fujifilm to Start PII Avigan Trial for COVID-19 in US
April 10, 2020
- MHLW Urges Drug Makers, Wholesalers to Ensure Stable Drug Supplies amid Emergency
April 10, 2020
- No Impact from Coronavirus Outbreak Seen with February Detailing Number: Intage
April 10, 2020
- Indian Export Restriction Lifted, but Japan Imports Still Stalled
April 10, 2020
- MHLW Plans to Revise National Vaccine Certification Rules in June
April 10, 2020
- Astellas Boosts COVID-19 Measures after State of Emergency Declared; Daiichi Sankyo Partially Pausing Trials
April 10, 2020
- League of Lawmakers Urges MHLW to Help COVID-19 Drug/Vaccine Development
April 10, 2020
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
